EP1807156
Nýjar lyfjasamsetningar er nýtast í meðferð við svefnleysi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
26.10.2005EP published:
12.10.2016EP application number:
05798488.2
EP translation filed:
9.1.2017Grant published:
15.2.2017EPO information:
European Patent Register
Max expiry date:
25.10.2025Expiry date:
25.10.2023
Title:
NEW PHARMACEUTICAL FORMULATIONS USEFUL IN THE TREATMENT OF INSOMNIA
Timeline
Today
26.10.2005EP application
12.10.2016EP Publication
9.1.2017Translation submitted
15.2.2017Registration published
25.10.2023Expires
Owner
Name:
Orexo ABAddress:
Box 303, 751 05 Uppsala, SE
Inventor
Name:
PETTERSSON, AndersAddress:
SE-442 97 Kode, SE
Name:
NYSTRÖM, ChristerAddress:
SE-117 32 Stockholm, SE
Name:
BREDENBERG, SusanneAddress:
751 05 Uppsala, SE
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
0423800Date:
27.10.2004Country:
GB
Classification
Categories:
A61P 25/20, A61K 9/00, A61K 31/44
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 2.2.2017
Expires: 25.10.2017
Payer: Árnason Faktor
Number: 13
Paid: 30.10.2017
Expires: 25.10.2018
Payer: Árnason Faktor
Number: 14
Paid: 31.10.2018
Expires: 25.10.2019
Payer: Árnason Faktor
Number: 15
Paid: 25.10.2019
Expires: 25.10.2020
Payer: Tego ehf.
Number: 16
Paid: 22.10.2020
Expires: 25.10.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 27.10.2021
Expires: 25.10.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 27.10.2022
Expires: 25.10.2023
Payer: Árnason Faktor ehf.